Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;29(3):817-819.
doi: 10.3350/cmh.2023.0155. Epub 2023 May 17.

Correspondence on Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes"

Seul Ki Han  1   2   3 , Soon Koo Baik  1   2   3 , Moon Young Kim  1   2   3
Affiliations
Comment

Correspondence on Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes"

Seul Ki Han et al. Clin Mol Hepatol. 2023 Jul.
No abstract available

Keywords: Fibrosis; Non-alcoholic fatty liver disease; Steatohepatitis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Comment on

References

    1. Jeong S, Lim Y, Lee SK, Han HW. Subtypes of non-alcoholic fatty liver disease in terms of cardiovascular disease and dementia risks. Clin Mol Hepatol. 2023 May 8; doi: 10.3350/cmh.2023.0129. doi: - DOI - PMC - PubMed
    1. Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110:921–937. - PMC - PubMed
    1. Shang Y, Widman L, Hagström H. Nonalcoholic fatty liver disease and risk of dementia: A population-based cohort study. Neurology. 2022;99:e574–e582. - PMC - PubMed
    1. Elliott C, Frith J, Day CP, Jones DE, Newton JL. Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up. Dig Dis Sci. 2013;58:2383–2391. - PubMed
    1. Doward LC, Balp MM, Twiss J, Slota C, Cryer D, Brass CA, et al. Development of a patient-reported outcome measure for nonalcoholic steatohepatitis (NASH-CHECK): Results of a qualitative study. Patient. 2021;14:533–543. - PMC - PubMed